We are live on
!
Find out more
SCM
Soleus Capital Management Portfolio holdings
AUM
$2.47B
1-Year Est. Return
115.63%
This Fund
S&P 500
This Quarter
Est. Return
-13.52%
1 Year Est. Return
+115.63%
3 Year Est. Return
+435.52%
5 Year Est. Return
+604.31%
10 Year Est. Return
–
AUM
$641M
AUM Growth
-$134M
(-17%)
Cap. Flow
-$30.9M
Cap. Flow
% of AUM
-4.83%
Top 10 Holdings %
Top 10 Hldgs %
43.19%
Holding
88
New
23
Increased
22
Reduced
22
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SkinHealth Systems
SKIN
|
+$40.8M |
| 2 |
Organogenesis Holdings
ORGO
|
+$16.9M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$15.1M |
| 4 |
AnaptysBio
ANAB
|
+$14.3M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$21.8M |
| 2 |
OraSure Technologies
OSUR
|
+$20.7M |
| 3 |
HOLX
Hologic
HOLX
|
+$17.3M |
| 4 |
Smith & Nephew
SNN
|
+$12.3M |
| 5 |
10x Genomics
TXG
|
+$8.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 87.21% |
| 2 | Consumer Staples | 6.57% |
| 3 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intuitive Surgical
ISRG
$130B
| – | – |
-7,800
| Closed | -$2.35M |
|
77
Liquidia Corp
LQDA
$7.86B
| – | – |
-293,485
| Closed | -$2.11M |
|
78
NeoGenomics
NEO
$2.09B
| – | – |
-460,000
| Closed | -$5.59M |
|
|
79
OraSure Technologies
OSUR
$287M
| – | – |
-3,055,193
| Closed | -$20.7M |
|
80
Pacira BioSciences
PCRX
$1.09B
| – | – |
-22,250
| Closed | -$1.7M |
|
|
81
Smith & Nephew
SNN
$12.8B
| – | – |
-385,000
| Closed | -$12.3M |
|
|
82
10x Genomics
TXG
$6.08B
| – | – |
-106,139
| Closed | -$8.07M |
|
83
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.92B
| – | – |
-1,408,100
| Closed | -$127M |
|
|
TVRD
84
Tvardi Therapeutics
TVRD
$19M
| – | – |
-4,422
| Closed | -$1.93M |
|
|
ARYD
85
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| – | – |
-300,000
| Closed | -$2.94M |
|
|
OLK
86
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| – | – |
-53,961
| Closed | -$953K |
|
|
SIEN
87
DELISTED
Sientra, Inc.
SIEN
| – | – |
-164,134
| Closed | -$3.64M |
|
Similar funds
TW
M
SG
BL
FFA
GWM
Q
SIM
Soleus Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Soleus Capital Management held 88 positions worth $641M, down 17% from $775M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Soleus Capital Management withdrew a net $30.9M in Q2 2022, closing 16 positions and reducing 22 holdings. Its most notable exit was Illumina, an estimated $21.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 80% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Soleus Capital Management opened a new position in Tandem Diabetes Care worth $10.9M.
- Soleus Capital Management's largest Q2 2022 buy was Tandem Diabetes Care: 183,800 shares worth $10.9M.
- Soleus Capital Management added most to SkinHealth Systems in Q2 2022, an estimated $40.8M increase.
- Soleus Capital Management's biggest Q2 2022 reduction was Kyntra Bio, cutting an estimated $7.79M.
- Soleus Capital Management fully exited Illumina in Q2 2022, selling an estimated $21.8M.
- Soleus Capital Management's ten largest holdings make up 43% of its $641M portfolio in Q2 2022.
- Soleus Capital Management opened 23 new positions and closed 16 in Q2 2022.
- Soleus Capital Management's portfolio value fell 17% quarter-over-quarter to $641M.
Based on Soleus Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.